Officer received an award of 8,251 VRTX shares | OQRO Insider tradesWhy it stands out
Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Jul 21, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- Jul 23, 2026
OfficerGrant / award
Context
- Classification
grant award
Code A — grant or award
- Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0000875320-26-000253
- Filed / recorded
Added to OQROOct 2, 2026, 12:28 PM UTC Data qualityVerified: identifiers matched exactly IssuerVERTEX PHARMACEUTICALS INC / MA Reporting personOurania Tatsis Officer titleEVP, Chief Reg. & Quality Off. TableNon-derivative (Table I) Transaction dateJul 21, 2026 Acquired / disposedAcquired (A) Footnotes from the filing
- Restricted stock unit award that vests on 03/31/2030.
Around the same time
From a 13F filed Aug 14, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
Congress tradeHeld by the filer's joint per the disclosure. Disclosed 824 days after the transaction; reported as an official range, not an exact amount.
Compensation award — excluded from discretionary-purchase analysis.
